Relation of coronary artery disease in women <60 years of age to the combined elevation of serum lipoprotein (a) and total cholesterol to high-density cholesterol ratio

https://doi.org/10.1016/0002-9149(93)90286-LGet rights and content

Abstract

After age 40 years, coronary artery disease (CAD) is the leading cause of death in both women and men, yet in women the factors associated with, or leading to, CAD have been less extensively studied. This study examined the strength of association of a number of risk factors to CAD in groups of women <60 years of age with (n = 108) and without (n = 66) angiographically documented significant narrowing of coronary arteries. In univariate analyses, there were significant differences between control subjects and patients with regard to age (49 ± 6 vs 52 ± 7 years) and total lipids and apolipoproteins measured. The relative frequency of cigarette smoking and diabetes was higher and that of estrogen replacement therapy lower in patients with CAD than in control subjects. In multivariate analysis the following factors were independently associated with CAD (adjusted odds ratios and 95% confidence intervals): total cholesterol to high-density lipoprotein (HDL) cholesterol (1.91; 1.56 to 2.34); lipoprotein (a) (10.66; 3.51 to 32.35); estrogen replacement (0.24; 0.11 to 0.54); age (1.12; 1.04 to 1.18); and smoking (1.50; 0.98 to 2.29). The nonadjusted odds ratio of CAD, based on combined tercile values of lipoprotein (a) serum level and total cholesterol to HDL cholesterol ratio, was very low (0.15; 0.06 to 0.36) when both values were within the first tercile, but very high (16.63; 3.54 to 78.07) when both were in the third tercile. In conclusion, the serum lipoprotein (a) level and the total cholesterol to HDL cholesterol ratio were the risk factors most closely associated to CAD in women, and the determination of lipoprotein (a) should complement the measurement of classic lipids in the screening and the diagnostic workup of that disease.

References (33)

  • M Soma et al.

    Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal women

    Lancet

    (1991)
  • JA Hearn et al.

    Predictive value of lipoprotein (a) and other serum lipoproteins in the angiographic diagnosis of coronary artery disease

    Am J Cardiol

    (1990)
  • VW Armstrong et al.

    The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels

    Atherosclerosis

    (1986)
  • TJ Thom

    Cardiovascular disease mortality among United States women

  • KA Matthews et al.

    Menopause and risk factors for coronary heart disease

    N Engl J Med

    (1989)
  • D Thelle

    Women and coronary heart disease: a review with special emphasis on some risk factors

    Lipid Rev

    (1990)
  • Cited by (63)

    • Conditional risk factors for atherosclerosis

      2005, Mayo Clinic Proceedings
      Citation Excerpt :

      In an elderly cohort, an elevated Lp(a) level was an independent predictor of stroke and death due to vascular disease in men but not women.121 Risk of CHD may be increased synergistically in patients with elevated Lp(a) levels and low levels of HDL cholesterol.122 However, no such interaction was observed in the Framingham Offspring Study.123

    • Lack of association between lipoprotein(a) and coronary artery calcification in the genetic epidemiology network of arteriopathy (GENOA) study

      2004, Mayo Clinic Proceedings
      Citation Excerpt :

      In a study of 788 asymptomatic men aged 35 to 65 years and followed up for 10 years, elevated Lp(a) levels were associated with an increased CHD risk, especially in men with high LDL-C levels, low HDL-C levels, and hypertension.6 In another study, CHD risk was found to be increased synergistically in patients with elevated Lp(a) levels and low levels of HDL-C,25 although such an interaction was not observed in the Framingham Offspring Study.26 Whether Lp(a) is associated with a coronary atherosclerotic burden remains unclear.

    View all citing articles on Scopus

    This study was supported in part by the Research Center of the Montreal Heart Institute, Montreal, Quebec, Canada.

    View full text